Ontology highlight
ABSTRACT: Objectives
To retrospectively validate the new Chinese DIC scoring system (CDSS).Methods
This study retrospectively collected the information of 619 patients (371 cases with non-hematologic malignancies, 248 cases with hematologic malignancies) who suspected of DIC in Wuhan Union Hospital during 2013-4 to 2014-6. We validated CDSS by comparing it with three leading scoring systems, from International Society on Thrombosis and Haemostasis (ISTH), Japanese Association for Acute Medicine (JAAM) and Japanese Ministry of Health and Welfare (JMHW), and evaluated its prognostic value by 28 days mortality, APACHE II and SOFA score.Results
In non-hematologic malignancies, CDSS was more specific than JAAM (72.55% vs. 50.49%, p<0.05) and more sensitive than ISTH (77.07% vs. 62
SUBMITTER: Wang M
PROVIDER: S-EPMC4467973 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature